Biomarkers to Detect Endocrine Therapy Resistance
Biomarkers to Detect Endocrine Therapy Resistance
Recruiting · NCT06067503 · Registry updated 2026-08-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Biomarkers to Detect Endocrine Therapy Resistance | Carcinoma, Lobular, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Neoplastic Cells, Circulating, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, adenocarcinoma, breast cancer, breast disorder, breast lobular carcinoma, breast neoplasm, carcinoma, epithelial neoplasm, metastatic malignant neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-08-25 | NCT06067503 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Wisconsin, Madison | 265 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UW Carbone Cancer Center | Madison | United States | 11 |